Oxford Gene Technology (Southern) Limited

Active03247591 Private limited company
Incorporated
9 September 1996 (30 years)
Previously known as
Sense Proteomic Limited (until 9 December 2015)
Sensetherapeutic Limited (until 28 November 2000)
Industry
Research and experimental development on biotechnology (72110)
Directors
Shinichi Sato
Kenji Iwakabe
Owned by
Accounts type
Small
Region
South East
Address
Unit 5 Oxford Technology Park
4A Technology Drive
Kidlington
OX5 1GN

Filing status

Accounts due
31 December 2026
Last accounts
31 March 2025
Conf. stmt due
26 March 2027
Last conf. stmt
12 March 2026

Charges

Total
1
Outstanding
0
Part satisfied
0
Satisfied
1

Officers 5 active

Officer details are public data from the Companies House register.

Sato, Shinichi
Director · Appointed 30 April 2026
Japanese
Born April 1968 (58)
Iwakabe, Kenji
Director · Appointed 7 May 2025
Japanese
Born June 1975 (51)
Director · Appointed 28 April 2022
Also at Cytocell Limited, Oxford Gene Technology Limited, Oxford Gene Technology IP Limited · more companies
British
Born August 1971 (55)
Director · Appointed 30 January 2019
Also at Cytocell Limited, Oxford Gene Technology Limited, Oxford Gene Technology IP Limited · more companies
British
Born October 1980 (46)
Secretary · Appointed 10 March 2009
Also at Oxford Gene Technology Limited, Oxford Gene Technology IP Limited, Oxford Gene Technology (Operations) Ltd · more companies
British
Officer history (31 former)
30 April 2026
Appointed Sato, Shinichi as Director
30 April 2026
Resigned Oxlade, David Aufrere as Director
31 March 2026
Resigned Matsuo, Naohiko as Director
25 September 2025
Resigned Evans, Michael Robert, Dr as Director
7 May 2025
Appointed Iwakabe, Kenji as Director
27 March 2025
Appointed Matsuo, Naohiko as Director
27 March 2025
Resigned Ono, Takashi as Director
27 March 2025
Resigned Naoto, Kendo as Director
16 May 2024
Appointed Ono, Takashi as Director
28 March 2024
Resigned Kubota, Mamoru as Director
29 March 2023
Resigned Tsujimoto, Kenji as Director
29 March 2023
Appointed Kubota, Mamoru as Director
31 October 2022
Resigned Owen, David Andrew Arlwydd, Dr as Director
28 April 2022
Appointed Naoto, Kendo as Director
28 April 2022
Appointed Smith, Adrian Brian as Director
31 March 2022
Resigned Anson, John George as Director
30 January 2019
Appointed Williams, Gregory Alun as Director
19 October 2018
Resigned Hall, Timothy Richard as Director
23 February 2018
Appointed Anson, John George as Director
18 October 2017
Appointed Tsujimoto, Kenji as Director
17 July 2017
21 June 2017
Resigned Morgan, Sonia, Dr as Director
25 February 2016
Appointed Oxlade, David Aufrere as Director
31 January 2016
Resigned Cook, Timothy, Dr as Director
9 January 2012
Appointed Hall, Timothy Richard as Director
10 March 2009
Appointed Morgan, Sonia, Dr as Director
10 March 2009
Appointed Southern, Edwin Mellor, Prof Sir as Director
10 March 2009
Appointed Owen, David Andrew Arlwydd, Dr as Director
10 March 2009
Appointed Cook, Timothy, Dr as Director
10 March 2009
Appointed Evans, Michael Robert, Dr as Director
10 March 2009
Appointed Lenhardt, Anthony John as Secretary
10 March 2009
Resigned Goren, Amos Meir as Director
10 March 2009
Resigned Fallon, Rachel as Director
10 March 2009
Resigned Lyddon, Christopher Raymond as Secretary
10 March 2009
Resigned Lyddon, Christopher Raymond as Director
29 May 2008
Appointed Fallon, Rachel as Director
29 May 2008
Appointed Lyddon, Christopher Raymond as Director
24 December 2007
Resigned Long, Ronald Eric as Director
21 September 2006
Appointed Goren, Amos Meir as Director
21 September 2006
Resigned Lyddon, Christopher Raymond as Director
30 December 2002
Appointed Long, Ronald Eric as Director
30 December 2002
Appointed Lyddon, Christopher Raymond as Secretary
30 December 2002
Resigned Ward, John Barrie, Dr as Director
30 December 2002
Appointed Lyddon, Christopher Raymond as Director
30 December 2002
Resigned Farley, Joseph as Secretary
30 December 2002
30 December 2002
Resigned Mcneilly, David as Director
30 December 2002
Resigned Blackburn, Jonathan Michael, Doctor as Director
30 December 2002
Resigned Haycock, Paul, Dr as Director
5 December 2001
Appointed Farley, Joseph as Secretary
5 December 2001
Resigned Burr, Kenneth Edward as Secretary
18 October 2001
Appointed Mcneilly, David as Director
17 July 2000
17 July 2000
Appointed Burr, Kenneth Edward as Secretary
1 January 2000
Appointed Ward, John Barrie, Dr as Director
19 November 1998
Appointed Haycock, Paul, Dr as Director
3 December 1997
Resigned Sutherland, John David, Doctor as Director
3 December 1997
Resigned Sutherland, John David, Doctor as Secretary
3 December 1997
Appointed Kozlowski, Roland Zbigniew, Doctor as Secretary
9 September 1996
Appointed Waterlow Nominees Limited as Corporate Nominee Director
9 September 1996
Resigned Waterlow Nominees Limited as Corporate Nominee Director
9 September 1996
Appointed Sutherland, John David, Doctor as Secretary
9 September 1996
Appointed Sutherland, John David, Doctor as Director
9 September 1996
Resigned Waterlow Secretaries Limited as Corporate Nominee Secretary
9 September 1996
Appointed Blackburn, Jonathan Michael, Doctor as Director
9 September 1996
Appointed Waterlow Secretaries Limited as Corporate Nominee Secretary
9 September 1996

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Reg. no. 03845467
Former controllers (1)
6 April 2016
Ceased Edwin Mellor Southern — Owns 50–75% of shares

Group structure 5 companies

Ownership group derived from the Companies House PSC register

Oxford Gene Technology IP Limited
Cytocell Limited Owns 75–100% of shares
Oxford Gene Technology (Operations) Ltd Owns 75–100% of shares
Oxford Gene Technology (Southern) Limited This company Owns 75–100% of shares
Oxford Gene Technology Limited Owns 75–100% of shares

Financials

Balance sheet as at 31 March 2025 · small accounts

Net Assets
(£5,398,143)
Cash
£29,577
Profit
(£581)
Current Ratio
0.0x

Trend

Net Assets
(£10.0M) (£5.0M) £0 2024 2025 (£5,397,562) (£5,398,143)
Balance sheet detail
20252024
Current Assets£125,654£118,131
Cash£29,577£21,718
Creditors (< 1 year)£5,523,797£5,515,693
Net Current Assets(£5,398,143)(£5,397,562)
Net Assets(£5,398,143)(£5,397,562)
Shareholder Funds(£5,398,143)(£5,397,562)

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
4 June 2026Appointment of a director
30 April 2026Termination of appointment of a director
30 April 2026Termination of appointment of a director
12 March 2026Confirmation statement with no updates12 March 2026
2 December 2025Accounts for a small company31 March 2025
Show all recent filings

Some other companies at this address

Oxford Gene Technology (Operations) Ltd
Oxford Gene Technology IP Limited
Oxford Gene Technology Limited

Other companies in this industry

Harrow
Guildford
Macclesfield
Kidlington
Kidlington
Middlesex

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?